Skip to content

Insider · CIK 0001988312

Brian T Mackey

ceopresidentofficer

Files at CPSH (CPS TECHNOLOGIES CORP/DE/). First filing Mar 19, 2025, latest Oct 9, 2025.

Brian T Mackey files SEC Form 4 as CEO and president at CPSH (CPS TECHNOLOGIES CORP/DE/). Since Mar 19, 2025, Brian T Mackey has reported 2 open-market buys worth $81k and 0 open-market sells worth $0, the latest filed on Oct 9, 2025.

A track record needs three past buys with six months of prices behind them; Brian T Mackey has 0, so none is measured yet.

The newest scored trade: bought $50k of CPSH on Oct 8, 2025, filed Oct 9, 2025, scored 57 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$81k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CPSH: CPS TECHNOLOGIES CORP/DE/

CPSHOct 9, 2026 · close 3.54

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
57Moderate
CPSHbuy 5
CPS TECHNOLOGIES CORP/DE/
$50k
16,500 shares
+83%+155% from low-13% from high
46Moderate
CPSHbuy 2
CPS TECHNOLOGIES CORP/DE/
$31k
20,000 shares
--

Transactions

Every row this insider has filed, 14 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 24, 2026CPSH
CPS TECHNOLOGIES CORP/DE/
MOption exercise
Common Stock Option
+10,000$2.93$29k56,681Jun 26, 2026
May 28, 2026CPSH
CPS TECHNOLOGIES CORP/DE/
MOption exercise
Common Stock Options
+10,181$1.96$20k46,681Jun 2, 2026
May 21, 2026CPSH
CPS TECHNOLOGIES CORP/DE/
AGrant or award
Common Stock Optionderivative
+2,500$4.67$12k242,500May 26, 2026
May 21, 2026CPSH
CPS TECHNOLOGIES CORP/DE/
AGrant or award
Common Stock Optionderivative
+2,500$4.67$12k245,000May 26, 2026
May 21, 2026CPSH
CPS TECHNOLOGIES CORP/DE/
AGrant or award
Common Stock Optionderivative
+2,500$4.67$12k247,500May 26, 2026
May 21, 2026CPSH
CPS TECHNOLOGIES CORP/DE/
AGrant or award
Common Stock Optionderivative
+2,500$4.67$12k250,000May 26, 2026
Oct 8, 2025CPSH
CPS TECHNOLOGIES CORP/DE/
POpen-market purchase
Common Stock
+16,500$3.00$50k36,500Oct 9, 2025
Mar 17, 2025CPSH
CPS TECHNOLOGIES CORP/DE/
POpen-market purchase
Common Stock
+7,500$1.55$12k7,500Mar 19, 2025
Mar 18, 2025CPSH
CPS TECHNOLOGIES CORP/DE/
POpen-market purchase
Common Stock
+7,500$1.55$12k15,000Mar 19, 2025
Mar 19, 2025CPSH
CPS TECHNOLOGIES CORP/DE/
POpen-market purchase
Common Stock
+5,000$1.56$7,82120,000Mar 19, 2025
Feb 28, 2025CPSH
CPS TECHNOLOGIES CORP/DE/
AGrant or award
Common Stock Optionsderivative
+6,250$1.59$9,938221,250Mar 3, 2025
Feb 28, 2025CPSH
CPS TECHNOLOGIES CORP/DE/
AGrant or award
Common Stock Optionsderivative
+6,250$1.59$9,938227,500Mar 3, 2025
Feb 28, 2025CPSH
CPS TECHNOLOGIES CORP/DE/
AGrant or award
Common Stock Optionsderivative
+6,250$1.59$9,938233,750Mar 3, 2025
Feb 28, 2025CPSH
CPS TECHNOLOGIES CORP/DE/
AGrant or award
Common Stock Optionsderivative
+6,250$1.59$9,938240,000Mar 3, 2025

Questions about Brian T Mackey

Answered from the filings on this page, as of the latest one.

Is Brian T Mackey buying or selling?

Not in the last 12 months. Brian T Mackey's latest open-market trade on SEC Form 4 was bought $50k of CPSH on Oct 8, 2025.

How did Brian T Mackey's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian T Mackey has 0.

Where does Brian T Mackey file Form 4?

Brian T Mackey has filed Form 4 at CPSH (CPS TECHNOLOGIES CORP/DE/) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.